Moderna's Cost-Cutting Pays Off, Shares Surge
Update: 2025-11-06
Description
Modernas third-quarter loss narrowed, boosted by cost-cutting efforts, as shares surged after beating Wall Streets expectations. Despite a 45% drop in Covid vaccine sales, the companys aggressive cost-cutting measures and new product developments, such as flu and skin cancer vaccines, offer hope for future growth.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
